Cargando…

The global burden of bacterial and viral zoonotic infections

Clin Microbiol Infect 2011; 17: 326–330 ABSTRACT: Bacterial and viral zoonotic infections comprise a practically endless, ever‐expanding list of pathogens that have the potential to induce human disease of varying severity, with varying means of transmission to humans (including vector‐borne and foo...

Descripción completa

Detalles Bibliográficos
Autor principal:	Christou, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Themed Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129620/ https://www.ncbi.nlm.nih.gov/pubmed/21129102 http://dx.doi.org/10.1111/j.1469-0691.2010.03441.x

Ejemplares similares

Endophthalmitis
por: Durand, M L
Publicado: (2013)

The microarray technology: facts and controversies
por: Lévêque, N., et al.
Publicado: (2012)

Interactions between malaria and human immunodeficiency virus anno 2014
por: Van geertruyden, J-P
Publicado: (2014)

Skirts as Flags: Transitional Justice, Gender and Everyday Nationalism in Kosovo
por: Krasniqi, Vjollca, et al.
Publicado: (2020)

Modelling in infectious diseases: between haphazard and hazard
por: Neuberger, A., et al.
Publicado: (2013)

Web‐based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience
por: Paolotti, D., et al.
Publicado: (2013)

Biological warfare, bioterrorism, and biocrime
por: Jansen, H. J., et al.
Publicado: (2014)

Applying proteomic technology to clinical virology
por: Mancone, C., et al.
Publicado: (2012)

Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018
por: Jit, Mark
Publicado: (2021)

Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic
por: Lapin, Brittany R., et al.
Publicado: (2021)

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies
por: Zhao, Jidi, et al.
Publicado: (2021)

Review of bacterial and viral zoonotic infections transmitted by dogs
por: Ghasemzadeh, I, et al.
Publicado: (2015)

Hepato‐preferential insulins: Is this the end, or the end of the beginning?
por: Russell‐Jones, D. L.
Publicado: (2016)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
por: Davies, M. J., et al.
Publicado: (2016)

Randomized, double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
por: Bergenstal, R. M., et al.
Publicado: (2016)

Signalling pathways underlying structural plasticity of dendritic spines
por: Patterson, Michael, et al.
Publicado: (2011)

NOX1, 2, 4, 5: counting out oxidative stress
por: Wingler, K, et al.
Publicado: (2011)

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
por: Heitz, Frederic, et al.
Publicado: (2009)

Modulation of vaccine response by concomitant probiotic administration
por: Maidens, Catherine, et al.
Publicado: (2013)

The expression and function of midkine in the vertebrate retina
por: Gramage, E, et al.
Publicado: (2014)

Midkine in repair of the injured nervous system
por: Yoshida, Yoshihiro, et al.
Publicado: (2014)

The virtual heart as a platform for screening drug cardiotoxicity
por: Yuan, Yongfeng, et al.
Publicado: (2015)

Evolving understanding on the aetiology of thermally provoked itch
por: Murota, H., et al.
Publicado: (2016)

Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials
por: Rosenstock, Julio, et al.
Publicado: (2016)

Randomized double‐blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4
por: Blevins, T., et al.
Publicado: (2016)

Formalization of the classification pattern: survey of classification modeling in information systems engineering
por: Partridge, Chris, et al.
Publicado: (2016)

Dual deep modeling: multi-level modeling with dual potencies and its formalization in F-Logic
por: Neumayr, Bernd, et al.
Publicado: (2016)

WESSBAS: extraction of probabilistic workload specifications for load testing and performance prediction—a model-driven approach for session-based application systems
por: Vögele, Christian, et al.
Publicado: (2016)

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches
por: Gómez, Valentí, et al.
Publicado: (2020)

Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
por: Mauskopf, Josephine, et al.
Publicado: (2021)

Prescribing medicines to older people—How to consider the impact of ageing on human organ and body functions
por: Drenth‐van Maanen, A. Clara, et al.
Publicado: (2019)

The clinical and therapeutic challenge of treating older patients in clinical practice
por: Roller‐Wirnsberger, Regina, et al.
Publicado: (2019)

Underrepresentation of the elderly in clinical trials, time for action
por: van Marum, Rob J.
Publicado: (2020)

Demographics in the 2020s—Longevity as a challenge for pharmaceutical drug development, prescribing, dispensing, patient care and quality of life
por: Stegemann, Sven, et al.
Publicado: (2020)

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics
por: Feufel, Markus A., et al.
Publicado: (2020)

Medication management needs information and communications technology‐based approaches, including telehealth and artificial intelligence
por: Eggerth, Alphons, et al.
Publicado: (2019)

Comparison of Postoperative Pain Management Outcomes in the United States and China
por: Wang, Hui, et al.
Publicado: (2021)

AI-driven streamlined modeling: experiences and lessons learned from multiple domains
por: Sunkle, Sagar, et al.
Publicado: (2022)

What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021)

Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030
por: Sim, So Yoon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6aruljhdla88hduptruuo6etf3